We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

328 hedge funds and large institutions have $5.19B invested in Amedisys in 2022 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 127 increasing their positions, 91 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

40% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 91

14% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 56

10% more capital invested

Capital invested by funds: $4.72B → $5.19B (+$473M)

3.11% more ownership

Funds ownership: 89.76% → 92.87% (+3.1%)

1% more funds holding

Funds holding: 324 → 328 (+4)

8% more call options, than puts

Call options by funds: $57.2M | Put options by funds: $52.8M

Holders
328
Holders Change
+4
Holders Change %
+1.23%
% of All Funds
5.17%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
64
Increased
127
Reduced
91
Closed
56
Calls
$57.2M
Puts
$52.8M
Net Calls
+$4.4M
Net Calls Change
-$6.63M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$57.7M
2
JP Morgan Chase
JP Morgan Chase
New York
+$45.5M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$33M
4
Millennium Management
Millennium Management
New York
+$32M
5
FCM
Frontier Capital Management
Massachusetts
+$25.2M

Top Sellers

1
Viking Global Investors
Viking Global Investors
Connecticut
-$63.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$49M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$33.1M
4
Ameriprise
Ameriprise
Minnesota
-$30.5M
5
CG
Carmignac Gestion
France
-$25.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
51
Oppenheimer Asset Management
New York
$13.5M +$453K +3,030 +4%
Legal & General Group
52
Legal & General Group
United Kingdom
$13.3M +$20.3K +136 +0.2%
Swiss National Bank
53
Swiss National Bank
Switzerland
$13.3M +$777K +5,200 +7%
PPA
54
Parametric Portfolio Associates
Washington
$13M +$427K +2,856 +4%
Federated Hermes
55
Federated Hermes
Pennsylvania
$12.8M +$9.19M +61,532 +474%
Boston Partners
56
Boston Partners
Massachusetts
$12.7M +$10M +67,194 +995%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$11.9M -$277K -1,851 -3%
Axa
58
Axa
France
$11.7M -$507K -3,396 -5%
LOAMS
59
Lombard Odier Asset Management (Switzerland)
Switzerland
$11.2M +$9.71M +65,000 New
AllianceBernstein
60
AllianceBernstein
Tennessee
$11.1M +$2.21M +14,826 +30%
Goldman Sachs
61
Goldman Sachs
New York
$10.6M -$544K -3,640 -6%
CI
62
Cambiar Investors
Colorado
$10.5M +$39.4K +264 +0.4%
AIG
63
American International Group
New York
$9.56M +$15.5K +104 +0.2%
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$9.53M +$317K +2,122 +4%
RCMC
65
RK Capital Management (Colorado)
Colorado
$9.46M +$8.2M +54,900 New
AACP
66
Advantage Alpha Capital Partners
California
$9.25M -$1.48M -9,878 -16%
State of Wisconsin Investment Board
67
State of Wisconsin Investment Board
Wisconsin
$9.15M +$2.93M +19,622 +59%
UBS AM
68
UBS AM
Illinois
$8.86M +$602K +4,027 +9%
BA
69
Bridgewater Associates
Connecticut
$8.27M +$1.86M +12,438 +35%
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
$8.19M +$316K +2,116 +5%
BAM
71
Bell Asset Management
Australia
$8.13M -$52K -348 -0.7%
UBS Group
72
UBS Group
Switzerland
$8.01M +$363K +2,431 +6%
SEI Investments
73
SEI Investments
Pennsylvania
$7.85M +$587K +3,931 +9%
New York State Teachers Retirement System (NYSTRS)
74
New York State Teachers Retirement System (NYSTRS)
New York
$7.65M – – –
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$7.39M -$555K -3,713 -8%
1 2
3
4 5

AMED Hedge Fund Activity: Q1 2022 in Review

328 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2022, worth a combined $5.19B — up 10% from $4.72B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new AMED positions and 56 closed out — a net gain of 8 holders — while 127 added to existing stakes and 91 trimmed.

The largest buyer was Mackenzie Financial, adding an estimated $57.7M. The largest seller was Viking Global Investors, exiting entirely with an estimated $63.3M sold.

  • 328 institutional investors held Amedisys (AMED) as of Q1 2022, up from 324 in Q4 2021.
  • Funds reported $5.19B of Amedisys stock for Q1 2022, up 10% quarter-over-quarter.
  • 64 funds opened new Amedisys positions in Q1 2022 and 56 closed out, a net change of +8 holders.
  • The largest Amedisys buyer in Q1 2022 was Mackenzie Financial, an estimated $57.7M added.
  • The largest Amedisys seller in Q1 2022 was Viking Global Investors, an estimated $63.3M sold.

Based on aggregated 13F filings for Q1 2022.